Entasis Therapeutics, a subsidiary of Innoviva, Inc., is developing a portfolio of innovative cures for serious drug-resistant bacterial infections, a global health crisis affecting the lives of millions of patients. Our deep pipeline of novel clinical and preclinical antibacterial programs is designed to revolutionize the way physicians treat serious bacterial diseases.
Company Details
- Employees
- 8
- Founded
- 2015
- Address
- 35 Gatehouse Drive, Waltham,ma 02451,united States
- Phone
- (781)810-0120
- ra****@****stx.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- entasistx.com
- Keywords
- Burlingame.
- HQ
- Waltham, MA
Entasis Therapeutics Questions
Entasis Therapeutics's helpline number is (781)810-0120
Entasis Therapeutics's website is entasistx.com
Entasis Therapeutics's LinkedIn profile is https://www.linkedin.com/company/entasis-therapeutics
Entasis Therapeutics has
8 employees.
View email and phone details for 8
employees at Entasis Therapeutics.
Entasis Therapeutics's industry is
Biotechnology Research
Entasis Therapeutics's top competitors are
Fulcrum Therapeutics,
Syndax Pharmaceuticals,
Innoviva,
Vertex Pharmaceuticals,
Cubist Pharmaceuticals,
La Jolla Pharmaceutical Company,
Innoviva Specialty Therapeutics, Inc.,
Dunad Therapeutics,
Enanta Pharmaceuticals,
Xenon Pharmaceuticals Inc..
Entasis Therapeutics's support email address is rachel.lewis@entasistx.com
Entasis Therapeutics's categories are Biotechnology Research
Entasis Therapeutics's founding year is 2015
